[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biolife Solutions (BLFS)

Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,562,447
  • Shares Outstanding, K 48,857
  • Annual Sales, $ 96,210 K
  • Annual Income, $ -4,600 K
  • EBIT $ -16 M
  • EBITDA $ -11 M
  • 60-Month Beta 1.94
  • Price/Sales 15.13
  • Price/Cash Flow 130.10
  • Price/Book 3.91

Options Overview Details

View History
  • Implied Volatility 42.21% (-6.45%)
  • Historical Volatility 47.34%
  • IV Percentile 1%
  • IV Rank 0.10%
  • IV High 188.31% on 03/26/26
  • IV Low 42.07% on 07/23/26
  • Expected Move (DTE 23) 2.72 (8.63%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 8
  • Volume Avg (30-Day) 168
  • Put/Call OI Ratio 0.26
  • Today's Open Interest 1,626
  • Open Int (30-Day) 1,551
  • Expected Range 28.81 to 34.25

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.01
  • Number of Estimates 1
  • High Estimate $-0.01
  • Low Estimate $-0.01
  • Prior Year $0.00
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
26.98 +17.78%
on 07/08/26
33.14 -4.10%
on 07/28/26
+3.48 (+12.30%)
since 06/29/26
3-Month
19.97 +59.14%
on 04/30/26
33.14 -4.10%
on 07/28/26
+11.79 (+58.98%)
since 04/29/26
52-Week
17.86 +77.94%
on 03/13/26
33.14 -4.10%
on 07/28/26
+9.68 (+43.80%)
since 07/29/25

Most Recent Stories

More News
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--LXP, BLFS, PSNL, and FNWD

NEW YORK , July 29, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of dollars for...

FNWD : 44.47 (+0.20%)
PSNL : 12.01 (+1.09%)
LXP : 60.85 (-0.12%)
BLFS : 31.54 (-1.38%)
Are NG, BLFS, NRIM Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

BLFS : 31.54 (-1.38%)
NG : 5.94 (+2.06%)
NRIM : 26.76 (-0.78%)
BioLife Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioLife Solutions, Inc. - BLFS

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of BioLife Solutions ...

BLFS : 31.54 (-1.38%)
RGEN : 142.16 (-2.19%)
Are UTZ, BLFS, FNWD Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

FNWD : 44.47 (+0.20%)
BLFS : 31.54 (-1.38%)
UTZ : 14.09 (+0.07%)
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of BioLife Solutions, Inc. (NASDAQ: BLFS)

NEW YORK , July 22, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of dollars for...

BLFS : 31.54 (-1.38%)
Shareholder Alert: Ademi LLP investigates whether BioLife Solutions, Inc. is obtaining a Fair Price for Public Shareholders

MILWAUKEE , July 22, 2026 /PRNewswire/ -- Ademi LLP is investigating BioLife (NASDAQ: BLFS) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction...

BLFS : 31.54 (-1.38%)
BLFS Stock Alert: Halper Sadeh LLC is Investigating Whether BioLife Solutions, Inc. is Obtaining a Fair Price for its Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transaction may contain terms that...

BLFS : 31.54 (-1.38%)
Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media

                  Fast-tracks Repligen’s leadership and customer solution offering in high-growth cell therapy market by adding BioLife’s differentiated, high-margin recurring revenue business...

RGEN : 142.16 (-2.19%)
BLFS : 31.54 (-1.38%)
BioLife Solutions Q1 Earnings Call Highlights

BioLife Solutions (NASDAQ:BLFS) reported first-quarter 2026 revenue of $27.5 million, up 25% year-over-year, as management pointed to continued strength in its biopreservation media (BPM) franchise and...

BLFS : 31.54 (-1.38%)
BioLife Solutions Reports First Quarter 2026 Financial Results

Total revenue of $27.5 million, up 25% over Q1 2025

BLFS : 31.54 (-1.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

See More Share

Business Summary

BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of...

See More

Key Turning Points

3rd Resistance Point 36.49
2nd Resistance Point 34.81
1st Resistance Point 33.40
Last Price 31.54
1st Support Level 30.31
2nd Support Level 28.63
3rd Support Level 27.22

See More

52-Week High 33.14
Last Price 31.54
Fibonacci 61.8% 27.30
Fibonacci 50% 25.50
Fibonacci 38.2% 23.70
52-Week Low 17.86

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.